.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
US Army
Baxter
McKesson
Healthtrust
Citi
Mallinckrodt
Argus Health
Farmers Insurance

Generated: June 26, 2017

DrugPatentWatch Database Preview

AVENTYL Drug Profile

« Back to Dashboard

Which patents cover Aventyl , and what generic Aventyl alternatives are available?

Aventyl is a drug marketed by Ranbaxy and Lilly and is included in two NDAs.

The generic ingredient in AVENTYL is nortriptyline hydrochloride. There are ten drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

Summary for Tradename: AVENTYL

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list15
Clinical Trials: see list1
Patent Applications: see list1,040
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AVENTYL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy
AVENTYL
nortriptyline hydrochloride
SOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Lilly
AVENTYL HYDROCHLORIDE
nortriptyline hydrochloride
CAPSULE;ORAL014684-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
AVENTYL HYDROCHLORIDE
nortriptyline hydrochloride
CAPSULE;ORAL014684-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AVENTYL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ranbaxy
AVENTYL
nortriptyline hydrochloride
SOLUTION;ORAL014685-001Approved Prior to Jan 1, 19823,922,305► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Fish and Richardson
Baxter
Mallinckrodt
Cantor Fitzgerald
Queensland Health
Deloitte
Accenture
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot